Press Releases Athersys, Inc.

Equities

ATHXQ

US04744L2051

Market Closed - OTC Markets Other stock markets 03:42:02 2024-04-26 pm EDT			5-day change	1st Jan Change
0.0044 ^USD	0.00%		-2.22%	-78.00%

Apr. 11	North American Morning Briefing : Stock Futures Edge Lower Ahead of PPI Inflation Gauge	DJ
Apr. 05	Athersys, Inc. Announces Board Changes	CI

Press Releases

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Athersys : Acquisition/Asset Disposal - Form 8-K	Apr. 05	PU
Athersys Reports Third Quarter 2023 Financial Results and Business Highlights	Nov. 17	AQ
Athersys Extends Near Term Liquidity with Proceeds from Warrant Inducement and Global ARDS License with Healios to Explore Strategic Alternatives	Nov. 17	AQ
Acute Respiratory Distress Syndrome Pipeline \| Clinical Trials and Key Companies	Nov. 08	AQ
The Street Reports: Guide to Penny Stocks Look Now! CLNV, ARAV, RDHL, ATHX, EPAZ	23-10-19	AQ
Athersys : Failure to Satisfy Listing Rule - Form 8-K	23-10-18	PU
Athersys Extends Near Term Liquidity with Proceeds from Warrant Inducement and Global ARDS License with Healios to Explore Strategic Alternatives	23-10-16	BU
Athersys Reports Interim Analysis Results of MASTERS-2 Clinical Study with MultiStem in Ischemic Stroke, Signs Memorandum of Understanding for Global ARDS License with Healios	23-10-11	AQ
Athersys Reports Interim Analysis Results of MASTERS-2 Clinical Study with MultiStem in Ischemic Stroke, Signs Memorandum of Understanding (MOU) for Global ARDS License with Healios	23-10-10	BU
Athersys Licenses its Animal Health Assets to Ardent Animal Health	23-10-03	BU
Athersys Director Jane Wasman Appointed Board Chair	23-10-02	BU
Grant Awarded to Newcastle University to Research Athersys MultiStem in Machine Perfusion Prior to Kidney Transplantation	23-09-07	AQ
Grant Awarded to Newcastle University to Research Athersys’ MultiStem® in Machine Perfusion Prior to Kidney Transplantation	23-09-06	BU
Athersys : 2022 Annual Report	23-08-20	PU
Athersys : Offering - Form 8-K	23-08-18	PU
Athersys, Inc. Announces Pricing of $3.5 Million Public Offering	23-08-17	BU
Athersys Reports Second Quarter 2023 Financial Results and Business Highlights	23-08-16	BU
Athersys Appoints Neema Mayhugh, PhD to its Board of Directors	23-08-14	AQ
Athersys Appoints Neema Mayhugh, PhD to its Board of Directors	23-08-11	BU
Athersys : Failure to Satisfy Listing Rule - Form 8-K	23-07-31	PU

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Press Releases Athersys, Inc.

Equities

ATHXQ

US04744L2051

Press Releases

Filters